Immune thrombocytopenic purpura induced by the COVID‑19 vaccine after the second dose in a 78‑year‑old patient: A case report

Liu,Wenhui; Wu,Tao; Xue,Feng; Tian,Hongjuan; Song,Rui; Bai,Hai

doi:10.3892/etm.2022.11517

Immune thrombocytopenic purpura induced by the COVID‑19 vaccine after the second dose in a 78‑year‑old patient: A case report

Authors:
- Wenhui Liu
- Tao Wu
- Feng Xue
- Hongjuan Tian
- Rui Song
- Hai Bai
View Affiliations

Affiliations: Department of Hematology, The 940th Hospital of Joint Logistics Support Force of The Chinese People's Liberation Army, Lanzhou, Gansu 730050, P.R. China
Published online on: July 19, 2022 https://doi.org/10.3892/etm.2022.11517
Article Number: 580
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Coronavirus disease 2019 (COVID‑19) has become a global pandemic, but treatment options remain limited. Up to now, vaccination has been the main strategy to prevent transmission and reduce disease severity. However, with follow‑up observations after massive vaccination, immune thrombocytopenic purpura (ITP) induced by COVID‑19 vaccines has attracted the attention of investigators. The present study reported the case of a 78‑year‑old elderly female who presented with ‘oral bleeding for 2 days and scattered bleeding spots on the extremities for 1 day’ after vaccination with the COVID‑19 vaccine (Vero Cells), and blood routine analysis indicated a white blood cell count of 6.27x10⁹/l, hemoglobin levels of 144 g/l and a low platelet (PLT) count of 1x10⁹/l. Bone marrow cytomorphology showed thrombocytopenia, while no platelet‑producing megakaryocytes were observed. The patient was diagnosed with ITP and given symptomatic and supportive treatment, such as prednisone acetate 1 mg/kg, recombinant human thrombopoietin, intravenous injection of human immunoglobulin 0.4 g/kg and prevention of bleeding. At 1 week after the treatment started, the patient's PLT count began to increase, and 9 days later, it returned to normal levels. The aim of the present study was to raise the awareness of medical staff regarding this disease and to increase the vigilance of the general public. At the same time, the present study also provided an effective method to manage this type of adverse reaction to the COVID‑19 vaccine.

View Figures

View References

1	Gulali A: A comprehensive review on rational and effective treatment strategies against an invisible enemy; SARS Cov-2 infection. Exp Biomed Res. 3:293–311. 2020.
2	Wu Z and McGoogan JM: Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the chinese center for disease control and prevention. JAMA. 323:1239–1242. 2020.PubMed/NCBI View Article : Google Scholar
3	Lavezzo E, Franchin E, Ciavarella C, Cuomo-Dannenburg G, Barzon L, Del Vecchio C, Rossi L, Manganelli R, Loregian A, Navarin N, et al: Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo'. Nature. 584:425–429. 2020.PubMed/NCBI View Article : Google Scholar
4	Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, et al: Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 395:507–513. 2020.PubMed/NCBI View Article : Google Scholar
5	Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, et al: Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. Lancet Respir Med. 8:475–481. 2020.PubMed/NCBI View Article : Google Scholar
6	Ali E, Al-Maharmeh Q, Rozi WM, Habib MB and Yassin M: Immune thrombocytopenia purpura flare post COVID-19 vaccine. Ann Med Surg (Lond). 75(103164)2022.PubMed/NCBI View Article : Google Scholar
7	Bennett C, Chambers LM, Son J and Goje O: Newly diagnosed immune thrombocytopenia in a pregnant patient after coronavirus disease 2019 vaccination. J Obstet Gynaecol Res. 47:4077–4080. 2021.PubMed/NCBI View Article : Google Scholar
8	Zufferey A, Kapur R and Semple JW: Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP). J Clin Med. 6(16)2017.PubMed/NCBI View Article : Google Scholar
9	Zhang J: Clinical research progress of viral infection and primary immune thrombocytopenia. Clin Med Practice. 28:463–465. 2019.
10	Zhong Z, Su T, Zhang S, Chen Q, Ma R, Li Q, Li J and Dong S: Association between vaccination and thrombocytopenic purpura: Analysis of 13 cases. Chinese J Dis Control. 25:1014–1019. 2021.
11	Koch M, Fuld S, Middeke JM, Fantana J, von Bonin S and Beyer-Westendorf J: Secondary immune thrombocytopenia (ITP) associated with ChAdOx1 Covid-19 vaccination-a case report. TH Open. 5:e315–e318. 2021.PubMed/NCBI View Article : Google Scholar
12	David P and Shoenfeld Y: ITP following vaccination. Int J Infect Dis. 99:243–244. 2020.PubMed/NCBI View Article : Google Scholar
13	Jasaraj RB, Shrestha DB, Gaire S and Kassem M: Immune thrombocytopenic purpura following Pfizer-BioNTech COVID-19 vaccine in an elderly female. Cureus. 13(e16871)2021.PubMed/NCBI View Article : Google Scholar
14	King ER and Towner E: A case of immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination. Am J Case Rep. 22(e931478)2021.PubMed/NCBI View Article : Google Scholar
15	Cecinati V, Principi N, Brescia L, Giordano P and Esposito S: Vaccine administration and the development of immune thrombocytopenic purpura in children. Hum Vaccin Immunother. 9:1158–1162. 2013.PubMed/NCBI View Article : Google Scholar
16	Saudagar V, Patil S, Goh S and Pothiawala S: Vigilance regarding immune thrombocytopenic purpura after COVID-19 vaccine. Ir J Med Sci. 191:919–920. 2021.PubMed/NCBI View Article : Google Scholar
17	Gulali A, Rabia A, Zuhal MA and Haluk S: Immune thrombocytopenia; following seasonal flu vaccine and non-steroidal anti-inflammatory drug use. Professional Med J. 23:630–633. 2016.
18	Pellegrino P, Clementi E and Radice S: On vaccine's adjuvants and autoimmunity: Current evidence and future perspectives. Autoimmun Rev. 14:880–888. 2015.PubMed/NCBI View Article : Google Scholar
19	Nagasaki J, Manabe M, Ido K, Ichihara H, Aoyama Y, Ohta T, Furukawa Y and Mugitani A: Postinfluenza vaccination idiopathic thrombocytopenic purpura in three elderly patients. Case Rep Hematol. 2016(7913092)2016.PubMed/NCBI View Article : Google Scholar
20	Bhattacharjee S and Banerjee M: Immune thrombocytopenia secondary to COVID-19: A systematic review. SN Compr Clin Med. 2:2048–2058. 2020.PubMed/NCBI View Article : Google Scholar
21	Jawed M, Khalid A, Rubin M, Shafiq R and Cemalovic N: Acute immune thrombocytopenia (ITP) following COVID-19 vaccination in a patient with previously stable ITP. Open Forum Infect Dis. 8(ofab343)2021.PubMed/NCBI View Article : Google Scholar
22	Welsh KJ, Baumblatt J, Chege W, Goud R and Nair N: Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the vaccine adverse event reporting system (VAERS). Vaccine. 39:3329–3332. 2021.PubMed/NCBI View Article : Google Scholar
23	Hagihara M, Uchida T, Inoue M, Ohara S and Imai Y: Severe thrombocytopenia after COVID-19 mRNA vaccination. Rinsho Ketsueki. 62:1684–1687. 2021.PubMed/NCBI View Article : Google Scholar : (In Japanese).
24	Vaira LA, Podda L, Doneddu P, Careddu MG, Fozza C and De Riu G: Secondary thrombocytopenia after SARS-CoV-2 vaccine: Report of a case of hemorrhage and hematoma after minor oral surgery. J Stomatol Oral Maxillofac Surg. 123:95–97. 2021.PubMed/NCBI View Article : Google Scholar
25	Kuter DJ: Exacerbation of immune thrombocytopenia following COVID-19 vaccination. Br J Haematol. 195:365–370. 2021.PubMed/NCBI View Article : Google Scholar
26	Lee EJ, Cines DB, Gernsheimer T, Kessler C, Michel M, Tarantino MD, Semple JW, Arnold DM, Godeau B, Lambert MP and Bussel JB: Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination. Am J Hematol. 96:534–537. 2021.PubMed/NCBI View Article : Google Scholar
27	Visser C, Swinkels M, van Werkhoven ED, Croles FN, Noordzij-Nooteboom HS, Eefting M, Last-Koopmans SM, Idink C, Westerweel PE, Santbergen B, et al: COVID-19 vaccination in patients with immune thrombocytopenia. Blood Adv. 6:1637–1644. 2022.PubMed/NCBI View Article : Google Scholar